Growth Metrics

Bio-Techne (TECH) Other Non-Current Assets (2010 - 2026)

Bio-Techne's quarterly Other Non-Current Assets came in at $264.4 million in Q1 2026, down 1.72% year-on-year from $269.0 million in Q1 2025, and down 1.02% quarter-over-quarter from $267.1 million in Q4 2025.

Bio-Techne has reported Other Non-Current Assets for 17 years, with the latest figure at $264.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets fell 1.72% year-over-year to $264.4 million; the trailing twelve-month figure through Mar 2026 stood at $264.4 million (down 1.72% YoY), and the FY2025 full-year result was $12.3 million, down 95.33% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $264.4 million, down from $267.1 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $285.3 million in Q2 2023, with the low at $1.0 million in Q4 2024.
  • Average Other Non-Current Assets over 5 years is $159.6 million, with a median of $264.3 million recorded in 2024.
  • Year-over-year, Other Non-Current Assets sank 96.64% in 2024 and soared 25409.46% in 2025.
  • Tracing TECH's Other Non-Current Assets over 5 years: stood at $53.2 million in 2022, then slumped by 49.91% to $26.6 million in 2023, then tumbled by 96.07% to $1.0 million in 2024, then soared by 25409.46% to $267.1 million in 2025, then dropped by 1.02% to $264.4 million in 2026.
  • The last three Other Non-Current Assets figures came in at $264.4 million (Q1 2026), $267.1 million (Q4 2025), and $276.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 12.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 60,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.26 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.13 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 63.55 Mn
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn 264.37 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 264.37 Mn
Dec 31, 2025 267.08 Mn
Sep 30, 2025 276.56 Mn
Jun 30, 2025 12.33 Mn
Mar 31, 2025 268.99 Mn
Dec 31, 2024 1.05 Mn
Sep 30, 2024 9.46 Mn
Jun 30, 2024 264.27 Mn
Mar 31, 2024 272.14 Mn
Dec 31, 2023 26.65 Mn
Sep 30, 2023 281.58 Mn
Jun 30, 2023 285.30 Mn
Mar 31, 2023 283.35 Mn
Dec 31, 2022 53.19 Mn
Sep 30, 2022 53.90 Mn
Jun 30, 2022 46.83 Mn
Mar 31, 2022 45.98 Mn
Dec 31, 2021 37.11 Mn
Sep 30, 2021 11.59 Mn
Jun 30, 2021 11.58 Mn
Mar 31, 2021 11.59 Mn
Dec 31, 2020 11.34 Mn
Sep 30, 2020 10.28 Mn
Jun 30, 2020 13.52 Mn
Mar 31, 2020 12.17 Mn
Dec 31, 2019 9.25 Mn
Sep 30, 2019 5.59 Mn
Jun 30, 2019 5.18 Mn
Mar 31, 2019 5.12 Mn
Dec 31, 2018 5.01 Mn
Sep 30, 2018 5.10 Mn
Jun 30, 2018 5.27 Mn
Mar 31, 2018 27.06 Mn
Dec 31, 2017 43.41 Mn
Sep 30, 2017 44.57 Mn
Jun 30, 2017 3.62 Mn
Mar 31, 2017 2.43 Mn
Dec 31, 2016 42.69 Mn
Sep 30, 2016 4.11 Mn
Jun 30, 2016 1.92 Mn
Mar 31, 2016 1.47 Mn
Dec 31, 2015 1.59 Mn
Sep 30, 2015 1.76 Mn
Jun 30, 2015 1.85 Mn
Mar 31, 2015 1.94 Mn
Dec 31, 2014 1.70 Mn
Sep 30, 2014 1.83 Mn
Jun 30, 2014 1.08 Mn
Mar 31, 2014 2.27 Mn
Dec 31, 2013 2.37 Mn
Sep 30, 2013 2.49 Mn
Jun 30, 2013 3.33 Mn
Mar 31, 2013 3.08 Mn
Dec 31, 2012 3.03 Mn
Sep 30, 2012 2.84 Mn
Jun 30, 2012 1.85 Mn
Mar 31, 2012 1.62 Mn
Dec 31, 2011 1.22 Mn
Sep 30, 2011 11.30 Mn
Jun 30, 2011 1.32 Mn
Mar 31, 2011 1.20 Mn
Dec 31, 2010 440,000.00
Sep 30, 2010 477,000.00
Jun 30, 2010 523,000.00